Vident Advisory’s Hims & Hers Health HIMS Stock Holding History

Vident Advisory’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-6,121	Closed	-$347K	–	1679
2025 Q3	$347K	Sell	6,121 -30,387	-83%	-$1.56M	﹤0.01%	1338
2025 Q2	$1.82M	Buy	36,508 +8,619	+31%	+$390K	0.02%	531
2025 Q1	$824K	Buy	+27,889	New	+$1.04M	0.01%	799
2024 Q2	–	Sell	-20,450	Closed	-$316K	–	1457
2024 Q1	$316K	Sell	20,450 -1,095	-5%	-$12.3K	0.01%	996
2023 Q4	$192K	Buy	+21,545	New	+$159K	﹤0.01%	1226

Other funds holding HIMS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vident Advisory's HIMS Position: Q4 2025 in Review

Vident Advisory sold out of Hims & Hers Health (HIMS) in Q4 2025, closing a stake of 6,121 shares — an estimated $347K sold.

Vident Advisory first reported a position in HIMS in Q4 2023 and held it in 5 quarters. The position peaked at $1.82M in Q2 2025. 485 funds tracked by Wall St. Rank hold HIMS as of Q4 2025.

Vident Advisory reported no remaining Hims & Hers Health position as of Q4 2025 after selling out during the quarter.
Vident Advisory sold 6,121 Hims & Hers Health shares in Q4 2025, an estimated $347K.
Vident Advisory first reported a position in Hims & Hers Health in Q4 2023 and held it in 5 quarters.
Vident Advisory's Hims & Hers Health position peaked at $1.82M in Q2 2025.
485 funds tracked by Wall St. Rank held Hims & Hers Health as of Q4 2025.

Based on Vident Advisory's 13F filing for Q4 2025, filed 18 Feb 2026.